MyelinWatch EL
← Studies & programmes
Myelin repairNot tested in peopleResearch, not an established treatment

Human cell spheroids: a laboratory model of myelin injury and repair

Published by MyelinWatch:

Organisation
Ramesan et al. research team

Human iPSC myelin spheroid model · Researchers grew three-dimensional tissue spheres from human induced pluripotent stem cells, including myelin-producing oligodendrocytes and microglia. They induced myelin injury to study how human cells clear debris and form new myelin around nerve fibres, a process relevant to multiple sclerosis (MS).

What is the approach?

Scientists grow three-dimensional spheres from human stem cells with myelin-making oligodendrocytes and microglia, then deliberately injure their myelin. The model lets them observe debris clearance and formation of new sheaths in a dish; it is a laboratory research tool, not a cell treatment given to people with MS.

Approach source: Nature Neuroscience — original spheroid-model article ↗

What is being studied

Researchers grew three-dimensional tissue spheres from human induced pluripotent stem cells, including myelin-producing oligodendrocytes and microglia. They induced myelin injury to study how human cells clear debris and form new myelin around nerve fibres, a process relevant to multiple sclerosis (MS).

Research stage

Not tested in people

Research so far is in laboratory cells or animal models.

What we know so far

The peer-reviewed paper reports myelin fragmentation, microglial uptake of debris, generation of new oligodendrocytes and new thinner myelin sheaths around axons. Remyelination was observed in only about half of differentiations. Developmental maturity is another limitation: stem-cell-derived models may not fully reflect adult tissue. This is evidence that the cell model reproduces selected repair processes. It does not reproduce every feature of adult MS and has no patient outcome.

What this means for patients today

No person with MS was treated in this study. The model may help future research and early screening of candidate compounds, but it is not a therapy, a clinical trial or proof of remyelination in patients. It creates no established treatment access in Greece.

Treatment or approach
Human stem-cell spheroid model of myelin injury and repair
How it is intended to work
Human induced pluripotent stem cell-derived spheroids with oligodendrocytes and microglia
Where the study is running
Laboratory research; no treatment access in Greece
Source: Nature Neuroscience — Ramesan et al. — original peer-reviewed research article ↗Source: PubMed — Nature Neuroscience original article PMID 42823475 ↗
Published by MyelinWatch
Last substantive MyelinWatch update

Programme updates — newest research developments first

  1. Peer-reviewed laboratory model using human stem-cell-derived tissue; no patients treatedResearch event/source date:

    Human cell spheroids model myelin injury and repair in the laboratory

    A Nature Neuroscience paper published on 1 October 2026 describes three-dimensional spheroids made from human induced pluripotent stem cells. They contain myelinating oligodendrocytes and responsive microglia. After experimentally induced myelin injury, researchers observed debris clearance, generation of new oligodendrocytes and new, thinner myelin sheaths around axons. Remyelination was observed in only about half of differentiations. Developmental maturity is another limitation: stem-cell-derived models may not fully reflect adult tissue. The model can help study repair mechanisms and screen candidate compounds, but a spheroid cannot reproduce all features of adult multiple sclerosis (MS).

    Source: Nature Neuroscience — Ramesan et al. — original peer-reviewed research article ↗Source: PubMed — Nature Neuroscience original article PMID 42823475 ↗